Tele: 561.316.3330
Breaking Medical Device News

Friday, October 15, 2021
HomeTeVido BioDevicesTeVido BioDevices Announces Appointment of Dr. John Harris to Advisory Board

TeVido BioDevices Announces Appointment of Dr. John Harris to Advisory Board

TeVido BioDevices (cellular therapy to treat loss of pigmentation) today announced the appointment to the advisory board of Dr. John Harris, Director of the Vitiligo Clinic and Research Center at the University of Massachusetts Medical School. Dr. Harris will leverage his extensive experience in the research, diagnosis and treatment of vitiligo to help address significant unmet needs in reconstructive and cosmetic procedures utilizing autologous cell therapy (using a patient’s own tissue) for patients with vitiligo as well as nipple areola reconstruction for breast cancer survivors.

Laura Bosworth, TeVido CEO:  “TeVido’s mission has always been about helping patients to feel “whole” again.”  Bosworth added, “As we developed our cell therapy techniques to re-pigment the nipple areola lost due to breast cancer, we realized the procedure could benefit patients with vitiligo. Bringing Dr. Harris on our advisory board will accelerate our development plan to make a meaningful difference in the lives of those suffering from vitiligo, while we expand treatment options to include areola re-pigmentation and scarring.”

Vitiligo is a skin condition characterized by the appearance of white patches on any part of the body, such as the face, hands and arms. There is no cure, and it can be psychologically devastating.

“I am excited to contribute to the meaningful work TeVido is doing in the area of vitiligo treatment,” said Dr. Harris. “Vitiligo can cause severe emotional distress and social stigma. The ground-breaking techniques TeVido will bring to market will have a profound impact on the quality of patients’ lives.”

Dr. John Harris, Advisor, is a key opinion leader in vitiligo and has multiple research publications and textbook chapters on vitiligo. He serves on the Dermatology Foundation, Skin of Color Society, Global Vitiligo Foundation, Vitiligo Research Foundation, and the American Academy of Dermatology. He is an advisor and collaborator with AbbVie, Combe Inc, Genzyme/Sanofi, Stiefel/GSK, Aclaris Therapeutics, Celgene, and Pfizer. He is an ad hoc reviewer on grant applications and for multiple research journals. He lectures on vitiligo and other topics to local, regional, national, and international audiences.

Dr. Harris will be speaking on a panel with other vitiligo experts at World Vitiligo Day. The annual international event that brings global awareness to this life-altering skin condition, will be held in Detroit, Michigan on June 25th.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected

spot_img

Don't Miss

Ganymed Robotics Awarded a €2.5M Grant from the EC through the EIC Accelerator Program

Ganymed Robotics is developing a radically new approach to surgical robotics by combining computer vision, a branch of artificial intelligence, and mechatronics.

Global Healthcare Exchange Announces Acquisition of Explorer Surgical

Explorer Surgical will operate as a wholly-owned subsidiary of GHX.

Arlington Scientific Broadens Product Portfolio and Further Expands its Product Offering Through the acquisition of Non-Mammalian Blocking Buffers

Arlington Scientific, Inc. (ASI) is pleased to announce that it has acquired the non-mammalian blocking buffer product line from Clark McDermith, former owner of...

Laborie Medical Technologies Acquires Pelvalon

Laborie was represented by Piper Sandler (financial advisor) and Simpson Thacher & Bartlett LLP (legal advisor). Pelvalon was represented by J.P. Morgan Securities LLC (financial advisor) and Dorsey & Whitney LLP (legal advisor).

Herculite Products, Inc. Promotes Two Employees to New Roles

Paul Flaherty Chief Strategy Officer and Marco Angelone is being promoted to the role of Chief Financial Officer.

Prof. Joseph Kvedar Added to the Sweetch Advisory Board Member

Prof. Josdeph Kvedar is the current chair of the board at the American Telemedicine Association (ATA), formerly VP of Connected Health at Mass-Gen Brigham, co-chair of the American Medical Association (AMA) Digital Medicine Payment Advisory Group, and author of The Internet of Healthy Things and The New Mobile Age.

Sid Bala Named President of HealthChampion

Sid Bala is the former president and chief executive officer of alligatortek, a custom software applications company that was acquired by HealthChampion in 2020 where he led them for 27 years after he founded the business

Cochlear Announces FDA Approval and Clearance of first-of-its-kind Remote Care Capabilities for Nucleus and Baha Systems

The FDA approval for the cochlear implant solution and FDA clearance for the Baha solution is the first step in commercializing the product offering, anticipated spring 2022, and complement Cochlear's existing Remote Care offerings.

By using this website you agree to accept Medical Device News Magazine Privacy Policy